Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Valrocemide is an anticonvulsant and a derivative of valproic acid (Item No. 13033).1 In vivo, valrocemide protects against seizures induced by maximal electroshock (MES), pentylenetetrazole (PTZ; Item No. 18682), picrotoxin (Item No. 20771), or bicuculline (Item No. 11727) in mice (ED50s = 151, 132, 275, and 248 mg/kg, respectively). It prevents sound-induced seizures in Frings audiogenic-sensitive mice (ED50 = 52 mg/kg) and MES-induced seizures in rats (ED50 = 73 mg/kg). Valrocemide also prevents seizures in corneally kindled rats (ED50 = 161 mg/kg).
WARNING This product is not for human or veterinary use.
1. Anticonvulsant profile of valrocemide (TV1901): A new antiepileptic drug. Epilepsia 42(7), 831-836 (2001).